dermatology: the high variability in clinical assessments due to subjective interpretation. By providing standardized, quantifiable measurements, the platform enhances diagnostic accuracy, scalability, and inclusivity in clinical trials, particularly for underrepresented skin tones. MyMonitor helps pharmaceutical companies meet the FDA’s mandate for diverse patient populations in drug development, offering a solution that not only improves diagnostic processes but also optimizes clinical trial outcomes. With an integrated approach that combines artificial intelligence, advanced sensors, and real-time feedback, MyMonitor is poised to disrupt the dermatology and healthcare sectors, ensuring equitable and efficient care for all patients.